More recently updated clinical and laboratory diagnostic criteria for JMML have been proposed that incorporate NF1, RAS, and PTPN11 mutational status into the diagnostic assessment as follows [8]. This evidence concerns the gene NF1 and juvenile myelomonocytic leukemia.